Christopher Toombs
Direktor/Vorstandsmitglied bei IKARIA, INC.
Aktive Positionen von Christopher Toombs
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IKARIA, INC. | Direktor/Vorstandsmitglied | 01.03.2006 | - |
Faraday Pharmaceuticals, Inc.
 Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | - |
| Gründer | 01.01.2014 | - | |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Gründer | 01.01.2018 | - |
| Corporate Officer/Principal | 01.01.2018 | - | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | - | - |
Karriereverlauf von Christopher Toombs
Ehemalige bekannte Positionen von Christopher Toombs
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MuciMed, Inc. | Private Equity Investor | 01.03.2014 | 30.06.2016 |
Ausbildung von Christopher Toombs
| Wake Forest School of Medicine | Doctorate Degree |
| Wheaton College Graduate School | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Founder | 2 |
| Private Equity Investor | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
| MuciMed, Inc. | |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Health Technology |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Christopher Toombs
- Erfahrung
